Tenderwize
Zurück zur Suche

Open-house rebate agreements for Tacrolimus

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Jun 03, 2028 · 645 days left·Open·Supplies·Framework
Registrieren zum SpeichernOpen documents
Originaltitel der Bekanntmachung

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Tacrolimus, ATC L04AD02

62/100

Opportunity Score

Needs reviewMedium complexity
SuppliesFrameworkOpen
Warum diese Bewertung?

Chance

62 / 100

Komplexität

58 / 100

Risikofaktoren

The notice uses an open-procedure form but states that the arrangement is actually an open-house model outside ordinary...

Submission must go through the DTVP communication area, not the offer area; paper originals must arrive in duplicate an...

Tiefe Portfolioanalyse

Tiefe Analyse der Unternehmenspassung

Verwendet:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Überblick

Moderate opportunity

Wichtige Fakten

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Jul 2028
  • Non-exclusive rebate agreements for pharmaceutical products containing Tacrolimus, ATC L04AD02.
  • Open-house model with identical contract terms for all eligible pharmaceutical companies.
Vollständige Zusammenfassung anzeigen

This is an open-house pharmaceutical supply arrangement for Tacrolimus (CPV 33600000) led by AOK Bayern. It is not a competitive award procedure in the usual sense: the buyer states that all interested pharmaceutical companies meeting the stated eligibility condition can conclude identical, non-negotiable, non-exclusive rebate agreements. The contract period runs from 2026-08-01 to 2028-07-31, with contract entry possible at any time until 2028-06-03. Submission is possible electronically via DTVP with a qualified electronic signature or in paper form in duplicate originals; German-language requirements apply, and non-German documents must be submitted with a German translation.

Risiken

The notice uses an open-procedure form but states that the arrangement is actually an open-house model outside ordinary...

Submission must go through the DTVP communication area, not the offer area; paper originals must arrive in duplicate an...

Analyse kann unvollständig sein

Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.

Wichtige Anforderungen

Technical

  • The contract and the annex 'Determination of the contract products' must be completed and signed.

Eligibility

  • Only pharmaceutical companies are eligible as potential contract partners.

Administrative

  • A signed declaration of reliability must be submitted.

Auftraggeber

Ort

München, DEU

Website

www.aok.de

Auftraggeberprofil

Profil öffnen

Kennung

DE811695320

Tätigkeit

Health

Lose (1)

LOT-0001

Open-house rebate agreements for Tacrolimus

Open-house supply arrangement for Tacrolimus, ATC L04AD02, for pharmaceutical companies. The lot is described as a non-exclusive rebate agreement model with identical, non-individually negotiable contract terms. Performance is in Germany (DE212).

SuppliesFrameworkEU fundedElectronic submission

Ort

DE212, Germany

Dauer

Jul 2026 - Jul 2028

Kategorie

Pharmaceutical products

Frist

Deadline Jun 03, 2028

Vergabedetails

Veröffentlichungsdatum
14 Jun 2026
Sprachen
German

Referenzmetadaten

Rechtsgrundlage
32014L0024

Referenz-IDs

Ausschreibungs-ID
409342-2026

Dokumente (2)

Vergabedokument 1Einreichungsportal 1

Ähnliche Ausschreibungen

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta

Aug 30